Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trial

Cited by (174)

Items 101–174 of 174

1. Kassenärztliche Bundesvereinigung Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften
   Nationale VersorgungsLeitlinie · 2013
2. Evaluation and Management of Patients With Diabetes and Heart Failure: A Korean Diabetes Association and Korean Society of Heart Failure Consensus Statement
   Kyu‐Sun Lee, Jung Hyun Noh, Seong‐Mi Park, Kyung Mook Choi, Seok‐Min Kang, Kyu Chang Won, Hyun‐Jai Cho, Min Kyong Moon · 2023 · International Journal of Heart Failure
3. Empfehlungen zur Diagnostik und Behandlung von Patienten mit koronarer Herzkrankheit und Niereninsuffizienz
   H. Reinecke (Schriftführer), V. Brandenburg, P. Dominiak, J. Flöge, J. Galle, H. Geiger, B. Grabensee, F. de Haan, K. Heun, K. Ivens, A. Krian, J. Kroll, B. Kutkuhn, J. Mann, T. Philipp, T. Risler, B. E. Strauer, W. Thiel, G. Breithardt · 2006 · Clinical Research in Cardiology Supplements
4. Wytyczne ESC dotyczące cukrzycy, stanu przedcukrzycowego i chorób układu sercowo- -naczyniowego opracowane we współpracy z EASD
   ESC EASD · 2013 · Kardiologia Polska
5. Cissus quadrangularis extract mitigates diabetic cardiomyopathy by inhibiting RAAS activation, inflammation and oxidative stress
   Anees Ahmed Syed, Mohammad Irshad Reza, Mohammad Shafiq, Sanjana Kumariya, Roshan A. Katekar, Kashif Hanif, Jiaur Rahaman Gayen · 2022 · Biomarkers
6. Prevention of Macrovascular Disease in Type 2 Diabetic Patients: Blockade of the Renin-Angiotensin-Aldosterone System
   G. Neil Thomas, Brian Tomlinson · 2008 · Current Diabetes Reviews
7. Empfehlungen zur Diagnostik und Behandlung von Patienten mit koronarer Herzkrankheit und Niereninsuffizienz
   Holger Reinecke (Schriftführer), Vincent Brandenburg, Peter Dominiak, Jürgen Flöge, Jan Galle, Helmut Geiger, Bernd Grabensee, Fokko de Haan, Klaus Heun, Katrin Ivens, Werner Kleophas, Arno Krian, Johannes Kroll, Bernd Kutkuhn, Johannes Mann, Thomas Philipp, Teut Risler, Bodo E. Strauer, Wilfried Thiel, Günter Breithardt (Koordinator der AdHoc-Arbeitsgruppe), G. Breithardt · 2006 · Clinical Research in Cardiology Supplements
8. Critical Appraisal of Pharmaceutical Therapy in Diabetic Cardiomyopathy—Challenges and Prospectives
   Elina Khattab, Michaelia Kyriakou, Elena Leonidou, Stefanos Sokratous, Angeliki Mouzarou, Michael M. Myrianthefs, Nikolaos P. E. Kadoglou · 2025 · Pharmaceuticals
9. Diabetes und Herzinsuffizienz
   Christian Alfons Schneider, Roman Pfister, Erland Erdmann · 2010 · Herz
10. The Profile and Prognosis of Patients Hospitalised With Heart Failure
    Jindřich Špinar, Ondřej Ludka, Viktor Musil, Zbyněk Pozdíšek, Tomáš Pavlík, Ladislav Dušek, Jiří Vítovec, Lenka Špinarová, Miroslav Soucek · 2008 · International Heart Journal
11. The modern paradigm of pathophysiology, prevention and treatment of heart failure in type 2 diabetes mellitus
    Ж. Д. Кобалава, Vadim Medovchshikov, Nurlan Yeshniyazov, Э. Р. Хасанова · 2019 · Russian Journal of Cardiology
12. Efficacy and Safety of Angiotensin-Converting Enzyme Inhibitors in Patients With Left Ventricular Systolic Dysfunction and Hyponatremia
    Louise Balling, Lars Køber, Morten Schou, Christian Tobias Torp-Pedersen, Finn Gustafsson · 2013 · Journal of Cardiac Failure
13. Angiotensin Converting Enzyme Inhibition in Heart Failure: Clinical Trials and Clinical Practice
    Iain B. Squire · 2002 · Cardiovascular Drugs and Therapy
14. Aging and Remodeling of the RAS and RAAS and Related Pathways: Implications for Heart Failure Therapy
    Bodh I. Jugdutt · 2014 · Springer eBooks
15. HEART FAILURE AND DIABETES MELLITUS: SELECTED ISSUES OF ETIOLOGY AND PATHOGENESIS, PROGNOSIS AND TREATMENT
    Б. У. Марданов, Marina Korneeva, E. B. Akhmedova · 2016 · Rational Pharmacotherapy in Cardiology
16. Association of peripheral neuropathy with subclinical left ventricular dysfunction in patients with type 2 diabetes
    Yanyan Chen, Yi Wang, Ying Zhang, Mengying Li, Weiqing Zhang, Yingni Zhou, Xiangyang Liu, Jianfang Fu, Zuowei Lu, Qian Xu et al. · 2023 · Journal of Diabetes and its Complications
17. Organosulfur Compounds in Aged Garlic Extract Ameliorate Glucose Induced Diabetic Cardiomyopathy by Attenuating Oxidative Stress, Cardiac Fibrosis, and Cardiac Apoptosis
    Kumkum Sharma, Vibha Rani · 2023 · Cardiovascular & Hematological Agents in Medicinal Chemistry
18. Diabetes Mellitus and Cardiovascular Disease in the Elderly
    Gabriel Gregoratos, Gordon Leung · 2008 · Fundamental and clinical cardiology
19. Heart Failure in Diabetes mellitus: Clinical Features and Prognostic Implications
    Oleg Gorelik, Dorit Almoznino‐Sarafian, Irena Alon, Miriam Shteinshnaider, Shulamit Chachashvily, Irma Tzur, David Modai, Natan Cohen · 2005 · Cardiology
20. Perceived risk profile and treatment optimization in heart failure: an analysis from BIOlogy Study to TAilored Treatment in chronic heart failure
    Masatake Kobayashi, Adriaan A. Voors, Wouter Ouwerkerk, Kévin Duarte, Nicolas Girerd, Patrick Rossignol, Marco Metra, Chim Choy Lang, Leong L. Ng, Gerasimos S Filippatos et al. · 2021 · Clinical Cardiology
21. Glycemic status, non-traditional risk and left ventricular structure and function in the Jackson Heart Study
    Chizobam Ani, David J. Shavlik, Synnove Fonnebo Knutsen, Islam Abudayyeh, J. Banta, Emily Claire O'Brien, Robert John Mentz, Alain Gerald Bertoni, Gary E. Fraser · 2022 · BMC Cardiovascular Disorders
22. Reassessing the use of vasodilators in heart failure
    Robert Townsend Cole, Mihai Gheorghiade, Vasiliki V. Georgiopoulou, Divya Myadam Gupta, Catherine Norton Marti, Andreas P. Kalogeropoulos, Javed Butler · 2012 · Expert Review of Cardiovascular Therapy
23. Guía de práctica clínica de la ESC sobre diabetes, prediabetes y enfermedad cardiovascular, en colaboración con la European Association for the Study of Diabetes Grupo de Trabajo de diabetes, prediabetes y enfermedades cardiovasculares de la Sociedad Europea de Cardiología (ESC) y la European Association for the Study of Diabetes (EASD)
    Lars Rydén · 2016
24. The latest emerging drugs for the treatment of diabetic cardiomyopathy
    Minghao Li, Lin Liu, Chunyu Zhang, Li Deng, Yi Zhong, Bin Liao, Xiuying Li, Ying Wan, Jian Feng · 2024 · Expert Opinion on Pharmacotherapy
25. Terapia com inibidor da ECA com dosagens relativamente altas e risco de agravamento renal na insuficiência cardíaca crônica
    Renato De Vecchis, Giuseppina Di Biase, Carmelina Ariano, Carmela Cioppa, Anna Giasi, Antonio Ciccarelli, Armando Pucciarelli, Salvatore Cantatrione · 2011 · Arquivos Brasileiros de Cardiologia
26. A COMPREHENSIVE STUDY ON LITERATURE EVIDENCE, CLINICAL STUDIES AND PRACTICES OF HERBAL DRUGS FOR DIABETIC NEUROPATHY AND CARDIOMYOPATHY
    Arshiya Shamim, Hefazat Hussain Siddiqui, Tarique Mahmood, Paramdeep Bagga, Ranjan Kumar · 2017 · Asian Journal of Pharmaceutical and Clinical Research
27. Mechanisms for the defects in phospholipid signal transduction in diabetic cardiomyopathy.
    Paramjit S. Tappia, Naranjan S. Dhalla · 2014 · PubMed
28. Diabetes mellitus und Herzinsuffizienz: Epidemiologie und Therapie
    Roman Pfister, Erland Erdmann · 2008 · Herz
29. Endocrine cardiomyopathy: A review and pooled analysis of pathophysiology, diagnosis and clinical management
    Aref Albakri · 2019 · Research and Review Insights
30. Empfehlungen zur Diagnose und Behandlung der chronischen Herzinsuffizienz
    2002 · Bulletin des Médecins Suisses
31. Herbal Insights: Exploring the Therapeutic Potential of Indian Dietary Herbs in Diabetic Cardiomyopathy Management
    Ritu Ritu, Prabhnain Kaur, Vishal Kumar Vishwakarma, Aditya Narayan Singh, Ramesh K. Goyal · 2024 · Current Diabetes Reviews
32. Reversibility of Cardiac Remodeling in Hypertensive Patients with Heart Failure
    Anna Paini, Claudia Agabiti Rosei, Carolina De Ciuceis, Massimo Salvetti, María Lorenza Muiesan · 2023 · Updates in hypertension and cardiovascular protection
33. Chronic heart failure in patients with type 2 diabetes mellitus: prevalence, prognosis
    Sergey Valentinovich Kakorin, Аверкова Ирина Александровна, Ashot Musaelovich Mkrtumyan · 2015 · Cardiosomatics
34. Hyperkalemia as a limiting factor of neurohormonal blockade/modulation in everyday clinical practice
    Henrique Vasconcelos, Joana Cabral, Emília Moreira, Manuel Campelo, Sandra Amorim, Brenda Moura, Alexandra Sousa, Roberto Magalhães Pinto, Paulo Maia-Araújo, Cláudia Camila Dias et al. · 2022 · Revista Portuguesa de Cardiologia
35. Hyperkalemia and management of renin-angiotensin-aldosterone system inhibitors in chronic heart failure with reduced ejection fraction: A systematic review
    Cândida Fonseca, Dulce A. Brito, Patrícia Quadros Branco, João Miguel Frazão, José Silva‐Cardoso, Paulo Bettencourt · 2020 · Revista Portuguesa de Cardiologia (English Edition)
36. The Impact of Diabetes in Older Adults
    Joshua I. Barzilay · 2012 · Springer eBooks
37. Head-to-head comparison of clinical, biochemical and functional effects of fosinopril and enalapril in patients with systolic heart failure
    Petar Otašević, Biljana Putniković, Zelimir Vukajlovic, Bojan Ilisic, Aleksandar Nešković · 2006 · Medicinski pregled
38. Kardiovaskulär wirksame Therapie bei Patienten mit Diabetes mellitus
    Stefanie Rosner, Wolfgang Köenig · 2017 · Der Diabetologe
39. A review of the conservative versus invasive management of ischemic heart failure with reduced ejection fraction
    Anthony Georges Matta, Patrick Ohlmann, Vanessa Nader, Laszlo Levai, Ryeonshi Kang, Didier Carrié, Jerome G. Roncalli · 2023 · Current Problems in Cardiology
40. Köpeklerde Geriatrik Kardiyoloji - Bölüm 1: Geriatriklerde Kalp Yetmezliğinin Klasifikasyonu ve Tedavisi
    Kürşad Turgut, Havva SÜLEYMANOĞLU, Merve Ertan, Mehmet Ege İNCE · 2017 · Kafkas Universitesi Veteriner Fakultesi Dergisi
41. Reducing the risk of heart failure in diabetes mellitus: review of new therapeutics
    Shreeharsh Godbole, Shreerang V Godbole · 2020 · International Journal of Basic & Clinical Pharmacology
42. The Impact of SGLT2i Therapy on the Onset and Prognosis of Heart Failure in Patients with Type 2 Diabetes
    Bogdan Timar, Adina Braha, Lucica Grigorică, Laura Gaiţă, Romulus Zorin Timar · 2020 · Timişoara Medical Journal
43. Diabetic Cardiomyopathy
    Francesco Paneni, Francesco Cosentino · 2015 · Springer eBooks
44. Cardiogenic shock: a call for aggressiveness
    Jo Dens · 2000 · European Heart Journal
45. Diabetic cardiomyopathy: phenotypes, mechanisms, and therapeutic targets
    Johnson, Emily Jean · 2015 · Research Exchange (Washington State University)
46. The mitochondrial calcium uniporter induces apoptosis in cardiomyocytes cultured with high-glucose medium by affecting mitochondrial function
    Xia Chen, Wenyun Guo, Zhe Jing, Tao Zhang, Zhaoqi Wu, Hengqiang Cui, Wenxue Zheng, Yongqing Chen, Hui Chen · 2020
47. Congestive Heart Failure
    Anna Norhammar, Isabelle Johansson, Inga Sigurros Thrainsdottir, Lars Rydén · 2016 · Wiley eBooks
48. eHEART: www.heartjnl.com
    2002 · Heart
49. Le traitement du patient âgé insuffisant cardiaque : synthèse des données disponibles en 2012
    Émilie Ferrat, M. Medioni, Julien Le Breton, L. Compagnon, Jacques Cittée, Sandrine Bercier, Vincent Renard, Claude Attali · 2012 · Les cahiers de l année gérontologique
50. Diabetes mellitus und Herzinsuffizienz
    Roman Pfister, Christian Alfons Schneider · 2011 · Der Diabetologe
51. Is more better? About dose levels of ACE inhibitors in chronic heart failure
    Karl B Swedberg · 2000 · European Heart Journal
52. Benefits of angiotensin-II receptor blockers. Are we going beyond blood pressure control?
    Massimo Volpe, Giuliano Tocci · 2006
53. AVALIAÇÃO DOPPLERECOCARDIOGRÁFICA DA FUNÇÃO DIASTÓLICA DO VENTRÍCULO ESQUERDO EM CRIANÇAS E ADOLESCENTES PORTADORES DE DIABETES TIPO 1
    Claudia Nunes Duarte dos Santos · 2011 · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
54. Diabetes and Coronary Surgery
    Zoltán Szabó · 2001
55. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD The Task Force on diabetes, pre-diabetes, and cardiovascular diseases of theEuropeanSocietyofCardiology(ESC)anddevelopedincollaboration
    Lars Rydén, Peter J. Grant, Jeroen Joost Bax, Robert H. Fagard, Roberto Ferrari, David Hasdai, Arno Wilhelmus Hoes, Paulus F. Kirchhof, Massimo Francesco Piepoli, Adam Torbicki et al. · 2014
56. Diabetic Cardiomyopathy: From Pathophysiology
    Konstantinos A. Gatzoulis · 2014
57. The roles of genetics and glycaemic control in the development of LVH and Heart Failure in Type 2 Diabetes
    Helen Parry · 2015 · Discovery Research Portal (University of Dundee)
58. Heart Failure: Complications of Type 2 Diabetes
    Sang‐Hoon Seol · 2019 · Journal of Korean Diabetes
59. Treatment of Patients with Heart failure and Type 2 Diabetes: a review of the literature
    Elisa Fabbri, Maurizio Nizzoli · 2019 · Italian Journal of Medicine
60. 7. Diabetes and Heart Failure: How to Treat Doubles Dangers
    Hiroshi Ito · 2019 · Nihon Naika Gakkai Zasshi
61. The Impact of Hyperglycemia on Left Ventricular Function in Type 2 Diabetic Patients
    Kushal Thakkar, R Agrawal, P Tanti, R.P. Agrawal · 2017 · RUHS Journal of Health Science
62. MOLECULAR MECHANISMS AND SIGNALING PATHWAYS OF DIABETIC CARDIOMYOPATHY
    Mahmoud Youssef · 2020 · Delta University Scientific Journal
63. Congestive Heart Failure
    Susan F. Lien, Jeffrey D. Alexis · 2011 · Springer eBooks
64. Congestive Heart Failure
    Inga Sigurros Thrainsdottir, Lars Rydén · 2010 · Wiley eBooks
65. Current Awareness
    2001 · Pharmacoepidemiology and Drug Safety
66. Heart Failure
    Francesco Paneni, Francesco Cosentino · 2015 · Springer eBooks
67. 7. Diabetes and Heart Failure: How to Treat Doubles Dangers
    Hiroshi Ito · 2019 · Nihon Naika Gakkai Zasshi
68. Study of microvascular complications in newly diagnosed diabetes mellitus
    Balaji Prasad Naik, Diwakr Naidu G · 2019 · International Journal of Advanced Research in Medicine
69. Studies on the antioxidative and antidiabetic effects of Xylitol and Erythritol in type 2 diabetes: a comparative study.
    Nontokozo Z. Msomi · 2021
70. Exploring the mechanism of diabetic cardiomyopathy treated with Qigui Qiangxin mixture based on UPLC-Q/TOF-MS, network pharmacology and experimental validation
    Quancheng Han, Yan Li, Yiding Yu, Huajing Yuan, Ziqi Wang, Yonghong Guo, Jingle Shi, Yitao Xue, Xiujuan Liu · 2024 · Scientific Reports
71. Diabetic Renal and Related Heart Disease
    Carl Erik Mogensen, N.H. Andersen · 2006 · Humana Press eBooks
72. Aging and Optimal Therapy of Systolic Heart Failure in the Elderly
    Nakul Chander Sharma, Bodh I. Jugdutt · 2014 · Springer eBooks
73. Additional file 1 of Glycemic status, non-traditional risk and left ventricular structure and function in the Jackson Heart Study
    Ani, Chizobam, David J. Shavlik, Synnove M.F. Knutsen, Islam Abudayyeh, J. Banta, O’Brien, Emily, Robert John Mentz, Alain Gerald Bertoni, Fraser, Gary · 2022 · Figshare
74. Additional file 1 of Glycated ACE2 reduces anti-remodeling effects of renin-angiotensin system inhibition in human diabetic hearts
    Marfella, Raffaele, Nunzia D’Onofrio, Mansueto, Gelsomina, Vincenzo Grimaldi, Maria Consiglia Trotta, Celestino Sardu, Ferdinando Carlo SASSO, Lucia Scisciola, Cristiano Amarelli, Esposito, Salvatore et al. · 2022 · Figshare